Evidence map›Paper›PMID 25862818›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

SCARB2/LIMP-2 Regulates IFN Production of Plasmacytoid Dendritic Cells by Mediating Endosomal Translocation of TLR9 and Nuclear Translocation of IRF7.

Hao Guo, Jialong Zhang, Xuyuan Zhang, Yanbing Wang, Haisheng Yu, Xiangyun Yin, Jingyun Li, Peishuang Du, Joel Plumas, Laurence Chaperot and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Lysosomal Membrane Protein SCARB2 Mediates the Pathogenesis of Diabetic Retinopathy Through the MAPK/ERK/MMP9 Signaling Pathway.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Signaling pathways and targeted therapies for psoriasis.Signal transduction and targeted therapy · 2023
    Review
  12. Article
  13. Review
  14. Review
  15. Type I Interferon Production of Plasmacytoid Dendritic Cells under Control.International journal of molecular sciences · 2021
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Hao GuoKey Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; University of Chinese Academy of Sciences, Beijing, BJ 100080, China;
Jialong ZhangKey Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China;
Xuyuan ZhangKey Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; University of Chinese Academy of Sciences, Beijing, BJ 100080, China;
Yanbing WangKey Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China;
Haisheng YuKey Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; University of Chinese Academy of Sciences, Beijing, BJ 100080, China;
Xiangyun YinKey Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; University of Chinese Academy of Sciences, Beijing, BJ 100080, China;
Jingyun LiKey Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; University of Chinese Academy of Sciences, Beijing, BJ 100080, China;
Peishuang DuKey Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China;
Joel PlumasDepartment of Research and Development, Etablissement Français du Sang Rhône-Alpes Grenoble, La Tronche 38701, France;
Laurence ChaperotDepartment of Research and Development, Etablissement Français du Sang Rhône-Alpes Grenoble, La Tronche 38701, France;
Jianzhu ChenKey Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139;
Lishan SuKey Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599; and.
Yongjun LiuKey Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; Baylor Institute for Immunology Research, Baylor Research Institute, Dallas, TX 75204.
Liguo ZhangKey Laboratory of Immunity and Infection, Institute of Biophysics, Chinese Academy of Sciences, Beijing, BJ 100101, China; liguozhang@ibp.ac.cn.
Chinese Academy of Sciences · CNInstitute of Biophysics · CNÉtablissement Français du Sang · FRUniversity of Chinese Academy of Sciences · CN

Funding

HIV co-infection and HCV-induced liver fibrosis in vivoR01AI095097 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SU, LISHAN · 2012 to 2016
$1.8M
HIV-1 Replication and Pathogenesis in vivoR01AI080432 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SU, LISHAN · 2009 to 2012
$1.4M
NIAID NIH HHS R01 AI080432NIAID NIH HHS R01 AI095097
6 · The paper itself

Abstract

Scavenger receptor class B, member 2 (SCARB2) is essential for endosome biogenesis and reorganization and serves as a receptor for both β-glucocerebrosidase and enterovirus 71. However, little is known about its function in innate immune cells. In this study, we show that, among human peripheral blood cells, SCARB2 is most highly expressed in plasmacytoid dendritic cells (pDCs), and its expression is further upregulated by CpG oligodeoxynucleotide stimulation. Knockdown of SCARB2 in pDC cell line GEN2.2 dramatically reduces CpG-induced type I IFN production. Detailed studies reveal that SCARB2 localizes in late endosome/lysosome of pDCs, and knockdown of SCARB2 does not affect CpG oligodeoxynucleotide uptake but results in the retention of TLR9 in the endoplasmic reticulum and an impaired nuclear translocation of IFN regulatory factor 7. The IFN-I production by TLR7 ligand stimulation is also impaired by SCARB2 knockdown. However, SCARB2 is not essential for influenza virus or HSV-induced IFN-I production. These findings suggest that SCARB2 regulates TLR9-dependent IFN-I production of pDCs by mediating endosomal translocation of TLR9 and nuclear translocation of IFN regulatory factor 7.

Indexed as

Blotting, WesternCells, CulturedDendritic CellsEndosomesFlow CytometryFluorescent Antibody TechniqueHumansInterferon Regulatory Factor-7Interferon Type ILysosomal Membrane ProteinsProtein TransportReal-Time Polymerase Chain ReactionReceptors, ScavengerToll-Like Receptor 9Interferon Regulatory Factor-7Interferon Type IIRF7 protein, humanLysosomal Membrane ProteinsReceptors, ScavengerSCARB2 protein, humanTLR9 protein, humanToll-Like Receptor 9

Identifiers

PMID25862818
PMCPMC4506778
OpenAlexW1781925048

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.